In addition, previous studies have shown that Cyr61 could decrease the apoptosis of tumor cells, resulting in chemotherapy resistance in breast cancer, cervical cancer and acute myeloid leukemia24, 45, 46. This evidence concerns the gene CCN1 and breast carcinoma.